International Clinical Trial: Hainan Young Breast Cancer DCE-MRI Radiomics Molecular Subtype Prediction Study

Geneva, Oct. 27 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134579) titled 'Hainan Young Breast Cancer DCE-MRI Radiomics Molecular Subtype Prediction Study' on Oct. 16.

Study Type: Diagnostic test

Study Design: Diagnostic test for accuracy

Primary Sponsor: Hainan Medical College First Affiliated Hospital

Condition: Young breast cancer (primary malignant breast tumor in patients aged =40 years old)

Intervention: Gold Standard:The results of postoperative pathological immunohistochemistry (IHC) combined with FISH detection of breast lesions were used to determine the Luminal, HER2-positive and triple-negative molecular subtypes of breast cancer, which served as the clinical referenc...